Improving Speech in Noise Perception for Individuals With Age-related Hearing Loss
NCT ID: NCT07192757
Last Updated: 2025-12-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
36 participants
INTERVENTIONAL
2025-12-01
2026-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating a Deep Neural Noise-Reduction Algorithm for Hearing Aids
NCT07287774
Understanding Aided Speech Perception in Noise
NCT06377215
Improving Speech in Noise Using Noninvasive Stimulation
NCT07176936
fNIRs, Listening Effort, and Speech Intelligibility
NCT05330585
Speech Perception Training: Advanced Scoring and Feedback Methods
NCT05012774
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment A
participants will receive low level electrical stimulation to the auricular branch of the vagus nerve during the sound in noise task
transcutaneous auricular vagus nerve stimulation
active electrical stimulation applied to the cymba conchae of the left ear
Treatment B
Participants will receive stimulation to a control location
Sham Control
electrical stimulation applied to a location on the ear not innervated by the auricular vagus
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
transcutaneous auricular vagus nerve stimulation
active electrical stimulation applied to the cymba conchae of the left ear
Sham Control
electrical stimulation applied to a location on the ear not innervated by the auricular vagus
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal hearing or age-related hearing loss (with or without hearing aids)
Exclusion Criteria
* Implanted medical devices (eg., pacemaker) or ferrous metal
* Known history of heart conditions
* Medications that impact neurotransmitters released by vagus nerve stimulation
55 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Florida
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UF Health at the University of Florida
Gainesville, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB202500769
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.